• Forum
  • Market
  • Signals
  • Freelance
  • VPS
  • Quotes
  • Articles
  • CodeBase
  • Algo Forge
  • Documentation
  • AlgoBook
  • NeuroBook
  • Calendar
  • WebTerminal
  • About
  • Start VPS Trial
QuotesSections
  • Log in
  • Create an account
  • English
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Currencies / PTGX
  • Overview
  • US Stock Market
    • Technology
    • Financial
    • Real Estate
    • Energy
    • Basic Materials
    • Communication Services
    • Consumer Cyclical
    • Consumer Defensive
    • Healthcare
    • Industrials
    • Utilities
    • Other Symbols
  • Currencies
    • Major
    • Minor
    • America
    • Europe
    • Asia
  • Cryptocurrencies
  • Metals
  • Indexes
  • Commodities
  • Charts
  • Widgets
Back to US Stock Market

PTGX: Protagonist Therapeutics Inc

92.7200 USD 0.6300 (0.68%)
Sector: Healthcare Base: US Dollar Profit currency: US Dollar

PTGX exchange rate has changed by 0.68% for today. During the day, the instrument was traded at a low of 91.1400 and at a high of 94.8600.

Follow Protagonist Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart
  • M5
  • M15
  • M30
  • H1
  • H4
  • D1
  • W1
  • MN

PTGX News

  • 12:23 Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
  • 10:50 Citizens raises Protagonist Therapeutics stock price target on drug approvals
  • 23:18 Protagonist Therapeutics director Williams sells $1.48 million in shares
  • 05:07 Protagonist Therapeutics director sells $1.67 million in shares
  • 07:06 Top Biotech Stocks to Watch in 2026, According to Truist
  • 12:37 Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright
  • 06:41 Protagonist Stock: Assessing The 2026 Upside For Icotrokinra And Rusfertide (PTGX)
  • 03:22 Ali Asif, CFO of protagonist, sells $3.8m in PTGX stock
  • 03:22 Protagonist Therapeutics CEO Patel sells $4m in shares
  • 03:13 Protagonist Therapeutics chief medical officer sells $1.9m in shares

Frequently Asked Questions

What is PTGX stock price today?

Protagonist Therapeutics Inc stock is priced at 92.7200 today. It trades within 91.1400 - 94.8600, yesterday's close was 92.0900, and trading volume reached 200. The live price chart of PTGX shows these updates.

Does Protagonist Therapeutics Inc stock pay dividends?

Protagonist Therapeutics Inc is currently valued at 92.7200. Dividend policy depends on the company, while investors also watch 23.41% and USD. View the chart live to track PTGX movements.

How to buy PTGX stock?

You can buy Protagonist Therapeutics Inc shares at the current price of 92.7200. Orders are usually placed near 92.7200 or 92.7230, while 200 and 1.73% show market activity. Follow PTGX updates on the live chart today.

How to invest into PTGX stock?

Investing in Protagonist Therapeutics Inc involves considering the yearly range 74.0250 - 96.5400 and current price 92.7200. Many compare 0.70% and 23.41% before placing orders at 92.7200 or 92.7230. Explore the PTGX price chart live with daily changes.

What are Protagonist Therapeutics Inc stock highest prices?

The highest price of Protagonist Therapeutics Inc in the past year was 96.5400. Within 74.0250 - 96.5400, the stock fluctuated notably, and comparing with 92.0900 helps spot resistance levels. Track Protagonist Therapeutics Inc performance using the live chart.

What are Protagonist Therapeutics Inc stock lowest prices?

The lowest price of Protagonist Therapeutics Inc (PTGX) over the year was 74.0250. Comparing it with the current 92.7200 and 74.0250 - 96.5400 shows potential long-term entry points. Watch PTGX moves on the chart live for more details.

When did PTGX stock split?

Protagonist Therapeutics Inc has gone through stock splits historically. These changes are visible in , 92.0900, and 23.41% after corporate actions.

Daily Range
91.1400 94.8600
Year Range
74.0250 96.5400
Previous Close
92.0900
Open
91.1400
Bid
92.7200
Ask
92.7230
Low
91.1400
High
94.8600
Volume
200
Daily Change
0.68%
Month Change
0.70%
6 Months Change
23.41%
Year Change
23.41%
09 March, Monday
    • Online trading / WebTerminal
    • Free technical indicators and robots
    • Articles about programming and trading
    • Order trading robots on the Freelance
    • Market of Expert Advisors and applications
    • Follow forex signals
    • Low latency forex VPS
    • Traders forum
    • Trading blogs
    • Charts
    • Free widgets
    • MetaTrader 5 Trading Platform
    • MetaTrader 5 latest updates
    • News, implementations and technology
    • MetaTrader 5 User Manual
    • MQL5 language of trading strategies
    • MQL5 Cloud Network
    • MQL5 Algo Forge
    • Download MetaTrader 5
    • Install Platform
    • Uninstall Platform
    • About
    • Timeline
    • Terms and Conditions
    • Recurring Payment Agreement
    • Agency Agreement – Offer
    • Privacy and Data Protection Policy
    • Cookies Policy
    • Contacts and requests
  • MetaTrader 5
    Download MetaTrader 5 for Windows
    Download MetaTrader 5 for MacOS
    Download MetaTrader 5 for Linux
    Open MetaTrader 5 WebTerminal
    Scan to install from App Store
    Scan to install from Google Play
    Scan to install from Huawei AppGallery
    Scan to get Android APK file
    MQL5 Channels
    Scan to install from App Store
    Scan to install from Google Play
    Scan to install from Huawei AppGallery
    Scan to get Android APK file
    Economic Calendar
    Scan to install from App Store
    Scan to install from Google Play
    Scan to install from Huawei AppGallery
    Scan to get Android APK file
    Follow us on socials for top articles and CodeBase updates
    Not a broker, no real trading accounts
    35 Dodekanisou str, Germasogeia, 4043, Limassol, Cyprus
    Copyright 2000-2026, MetaQuotes Ltd